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α-Amino-ε -caprolactam (ACL) racemase (EC 5.1.1.15) is a 51 kDa enzyme that catalyzes the interconversion of L-and D-ACL. Recently, amino acid amide racemizing activity was found in ACL racemase [1] , and the combined method of ACL racemase with D-stereospecific amino acid amidase has been developed for industrial D-amino acid production from D,L-amino acid amide [2] . To clarify the structute-function relationships of ACL racemase, the crystal structures of the native and ε -caprolactam complex of ACL racemase were determined at 2.3 and 2.4 Å resolutions, respectively. ACL racemase belongs to the fold-type 1 group of PLP-dependent enzyme [3] . The crystal structures of serine racemase which belongs to fold-type 2 (PDB ID 1V71) and alanine racemase which belongs to fold-type 3(1SFT) were already determined. However, the crystal structure of fold-type 1 racemase has not been determined yet. If the structure of ACL racemase can be determined, we can understand the catalytic mechanism of racemase which belongs to fold-type 1 for the first time. The structure of ACL racemase is composed of three segments; (1) an N-terminal segment, (2) a large, pyridoxal phosphate (PLP) binding domain and (3) a C-terminal domain. The C4¸ in PLP covalently bonded to the ε -amino group of Lys267 forming the internal aldimine. From structural comparison with racemase belongs to fold-type 2 and 3, Lys267 and Tyr137 of ACL racemase may be candidates for two bases which are essential for proceeding racemization. The functional significance of ACL racemase will be discussed. FBPase (Fructose-1,6-bis-phosphatase) is a key enzyme in gluconeogenesis. Together with its counterpart enzyme in glycolysis, Phosphofructokinase, FBPase regulates glucose metabolism. FBPase forms a tetramer that is allosterically inhibited by AMP. The allosteric transition from the active R-state to the inactive T-state was intensely investigated over the last 20 years both biochemically and structurally and now serves as a textbook example for allosteric regulation in proteins. However, structural knowledge on FBPase stems almost exclusively from pig kidney/liver FBPase and thus may be biased toward this organism. Muscle FBPase is reported to be 100-fold more sensitive to AMP inhibition than liver FBPase while rodent liver FBPases are roughly 10-fold less sensitive to allosteric inhibition than their human or pig counterparts. Do the textbooks convey the correct picture of the allosteric transition? Or do they purport a biased and, thus, misleading view of the pig special case? To clarify this issue we determined several crystal structures of FBPase liver and muscle isoforms from rat, mouse, and human. Orotidine-5'-monophosphate decarboxylase (ODCase) catalyzes the decarboxylation of orotidine 5'-monophosphate (OMP) to uridine 5'-monophosphate (UMP), the last step of de novo pyrimidine biosynthesis. This enzyme is known as one of the most proficient enzymes, accelerating the decarboxylation reaction by 17 orders of magnitude without using any cofactors, metal ions or delocalization effects when compared to the spontaneous reaction in aqueous solution at neutral pH. The reaction is classified as an electrophilic substitution. We found that this enzyme surprisingly catalyzes two types of novel nucleophilic reactions in addition to the physiological electrophilic reaction. The first reaction is the conversion from 6-cyano-UMP into 6-hydroxyl-UMP (BMP). The conversion proceeds very slowly (t1/2 = about 1 day), but its product was confirmed by the high resolution crystal structure of the complex (at 1.4 Å resolution), the mass-spectroscopy, and the enzymological assay. Another novel reaction is the formation of covalent enzymeligand complexes with several substrate analogues. Again, the complexes were confirmed by crystallographic analysis and massspectroscopy. In addition, we determined numerous crystal structures of ODCase (wild-type and mutants) complexed with a variety of ligands at 1.2 -1.8 Å resolution. Several ligands displayed a distorted conformation at C6 of the pyrimidine ring, the reactive center. These discoveries suggest that ODCase can catalyze both nucleophilic and electrophilic substitutions, with distortion on the reactant part of the substrate part of catalysis. Details are shown in the presentation. Arylmalonate decarboxylase from Alcaligenes bronchiseptics ( A M D a s e , E C . 4 . 1 . 1 . 7 6 ) c a t a l y s e s a n e n a n t i o s e l e c t i v e decarboxylation of prochiral alpha-aryl-alpha-methylmalonate to produce optically pure alpha-arylpropionate in high enantiomeric excess in high yield. The SH group of the Cys188 residue together with Gly74 is known to play a crucial role in the reaction. By a double mutation, Gly74Cys/Cys188Ser results in an enzyme producing the totally opposite enantiomer. AMDase was crystallized into an orthorhombic crystal form, in that four molecules of the enzyme occupied a crystallographic asymmetric unit. The crystal structure was solved using the multiple isomorphous replacement method and crystallographically refined at a resolution of 2.1 Å. AMDase was composed of two compact domains of a/b-fold similar to the domain architectures in glutamate racemase and aspartate racemase. The structural details within domains and the relative orientations of the two domains were different from the racemases. The active site located in the groove between the two domains was formed by the Gly74-Thr75-Ser76 at the N-terminal face of a short helix, the side chains of Tyr80 and Tyr126, and the Cys188-Gly189-Gly190-Leu191 loop. The active-site structures were in varieties in the conformations of the residues in acompaying with the relative movement of the two domains. The findings suggest the inherent flexibility in the domain interface including the active site. One glycerol molecule, bound to the Gly74-Thr75-Ser76 region in a side-by-side contact, suggested a plausible binding site of the carboxylic groups of substrates. Based on the binding mode, a mechanism to explain the enantioselective reaction for substrates was proposed.
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